Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Monroe, LA
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Monroe, LA
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Boston, MA
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Greensboro, NC
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Anderson, SC
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Greer, SC
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Greer, SC
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Chattanooga, TN
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Germantown, TN
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Germantown, TN
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Austin, TX
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
San Antonio, TX
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Lynchburg, VA
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Truro,
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Truro,
Click here to add this to my saved trials
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Saint Louis, MO
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
A Phase 2 PoC in IBS Patients With the CRF1 Receptor Anatgonist, GSK876008
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated:  1/16/2018
Children's Nutrition Research Center
mi
from
Houston, TX
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated: 1/16/2018
Children's Nutrition Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated:  1/16/2018
Texas Children's Hospital
mi
from
Houston, TX
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated: 1/16/2018
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Premeire Pharmaceutical Research
mi
from
Tempe, AZ
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Premeire Pharmaceutical Research
mi
from
Tempe, AZ
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Medical Services of NWA
mi
from
Fayetteville, AR
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Medical Services of NWA
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
AGMG Clinical Research Institute
mi
from
Anaheim, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
AGMG Clinical Research Institute
mi
from
Anaheim, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Discovery Clinical Research
mi
from
Encinitas, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Discovery Clinical Research
mi
from
Encinitas, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
West Gastroenterology Medical Group
mi
from
Los Angeles, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
West Gastroenterology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Community Clinical Trials
mi
from
Orange, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Community Clinical Trials
mi
from
Orange, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Sharp Rees-Stealy Medical
mi
from
San Diego, CA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Sharp Rees-Stealy Medical
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Rocky Mountain Gastroenterology
mi
from
Lakewood, CO
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Arapahoe Gastrroenterology, PC
mi
from
Littleton, CO
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Arapahoe Gastrroenterology, PC
mi
from
Littleton, CO
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
South Denver Gastroenterology
mi
from
Lone Tree, CO
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
South Denver Gastroenterology
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Connecticut Gastroenterology Institute
mi
from
Bristol, CT
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Clinical Trials Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Research Consultants Group
mi
from
Hialeah, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Research Consultants Group
mi
from
Hialeah, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Horizon Institute for Clinical Research
mi
from
Hollywood, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Horizon Institute for Clinical Research
mi
from
Hollywood, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Mark Lamet, M.D.
mi
from
Hollywood, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Mark Lamet, M.D.
mi
from
Hollywood, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Southern Clinical Research Consultants
mi
from
Hollywood, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Southern Clinical Research Consultants
mi
from
Hollywood, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
A+ Research, Inc
mi
from
Miami, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
A+ Research, Inc
mi
from
Miami, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
United Medical Research
mi
from
New Smyrna Beach, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
United Medical Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Venture Research Institute, LLC
mi
from
North Miami Beach, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Venture Research Institute, LLC
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
West Wind'r Research & Development, LLC
mi
from
Tampa, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
West Wind'r Research & Development, LLC
mi
from
Tampa, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Shafran Gastroenterology Center
mi
from
Winter Park, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Florida Medical Clinic
mi
from
Zephyrhills, FL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Dekalb Gastroenterology Associates
mi
from
Decatur, GA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Dekalb Gastroenterology Associates
mi
from
Decatur, GA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Gastroenterology Associates of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Research Associates
mi
from
Newnan, GA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Research Associates
mi
from
Newnan, GA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
University Digestive Health Center
mi
from
Oak Forest, IL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
University Digestive Health Center
mi
from
Oak Forest, IL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Carle Clinic Association P.C.
mi
from
Urbana, IL
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Carle Clinic Association P.C.
mi
from
Urbana, IL
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Community Clinical Research Center
mi
from
Anderson, IN
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Community Clinical Research Center
mi
from
Anderson, IN
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Iowa Digestive Disease Center
mi
from
Clive, IA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Iowa Digestive Disease Center
mi
from
Clive, IA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Health Center of Louisiana
mi
from
Baton Rouge, LA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Health Center of Louisiana
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Clinical Trials Management
mi
from
Metairie, LA
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Clinical Trials Management
mi
from
Metairie, LA
Click here to add this to my saved trials
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated:  2/6/2018
Digestive Disorders Associates
mi
from
Annapolis, MD
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
A Multicenter, Open-label Trials to Evaluate the Long-term Safety and Tolerability of a New Balsalazide Disodium Tablet Formulation in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 2/6/2018
Digestive Disorders Associates
mi
from
Annapolis, MD
Click here to add this to my saved trials